Biblio

Found 1781 results

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Risk Factors

M. A. Slifer, Martin, E. R., Haines, J. L., and Pericak-Vance, M. A., “The ubiquilin 1 gene and Alzheimer's disease.”, N Engl J Med, vol. 352, no. 26, pp. 2752-3; author reply 2752-3, 2005.

P. Nowotny, Hinrichs, A. L., Smemo, S., Kauwe, J. S. K., Maxwell, T., Holmans, P., Hamshere, M., Turic, D., Jehu, L., Hollingworth, P., Moore, P., Bryden, L., Myers, A., Doil, L. M., Tacey, K. M., Gibson, A. M., McKeith, I. G., Perry, R. H., Morris, C. M., Thal, L., Morris, J. C., O'Donovan, M. C., Lovestone, S., Grupe, A., Hardy, J., Owen, M. J., Williams, J., and Goate, A., “Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.”, Am J Med Genet B Neuropsychiatr Genet, vol. 136B, no. 1, pp. 62-8, 2005.

H. Zhu, Gopalraj, R. K., Kelly, J. F., Bennett, D. A., and Estus, S., “Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.”, Neurosci Lett, vol. 381, no. 1-2, pp. 36-41, 2005.

A. Akomolafe, Lunetta, K. L., Erlich, P. M., Cupples, L. A., Baldwin, C. T., Huyck, M., Green, R. C., and Farrer, L. A., “Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.

K. - L. Huang, Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. Chih, Harari, O., Bertelsen, S., Fairfax, B. P., Czajkowski, J., Chouraki, V., Grenier-Boley, B., Bellenguez, C., Deming, Y., McKenzie, A., Raj, T., Renton, A. E., Budde, J., Smith, A., Fitzpatrick, A., Bis, J. C., DeStefano, A., Adams, H. H. H., M Ikram, A., van der Lee, S., Del-Aguila, J. L., Fernández, M. Victoria, Ibañez, L., Sims, R., Escott-Price, V., Mayeux, R., Haines, J. L., Farrer, L. A., Pericak-Vance, M. A., Lambert, J. Charles, van Duijn, C., Launer, L., Seshadri, S., Williams, J., Amouyel, P., Schellenberg, G. D., Zhang, B., Borecki, I., Kauwe, J. S. K., Cruchaga, C., Hao, K., and Goate, A. M., “A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.”, Nat Neurosci, vol. 20, no. 8, pp. 1052-1061, 2017.

A. C. Naj, Jun, G., Reitz, C., Kunkle, B. W., Perry, W., Park, Y. Son, Beecham, G. W., Rajbhandary, R. A., Hamilton-Nelson, K. L., San Wang, L. -, Kauwe, J. S. K., Huentelman, M. J., Myers, A. J., Bird, T. D., Boeve, B. F., Baldwin, C. T., Jarvik, G. P., Crane, P. K., Rogaeva, E., M Barmada, M., F Demirci, Y., Cruchaga, C., Kramer, P. L., Ertekin-Taner, N., Hardy, J., Graff-Radford, N. R., Green, R. C., Larson, E. B., St George-Hyslop, P. H., Buxbaum, J. D., Evans, D. A., Schneider, J. A., Lunetta, K. L., M Kamboh, I., Saykin, A. J., Reiman, E. M., De Jager, P. L., Bennett, D. A., Morris, J. C., Montine, T. J., Goate, A. M., Blacker, D., Tsuang, D. W., Hakonarson, H., Kukull, W. A., Foroud, T. M., Martin, E. R., Haines, J. L., Mayeux, R. P., Farrer, L. A., Schellenberg, G. D., Pericak-Vance, M. A., Albert, M. S., Albin, R. L., Apostolova, L. G., Arnold, S. E., Barber, R., Barnes, L. L., Beach, T. G., Becker, J. T., Beekly, D., Bigio, E. H., Bowen, J. D., Boxer, A., Burke, J. R., Cairns, N. J., Cantwell, L. B., Cao, C., Carlson, C. S., Carney, R. M., Carrasquillo, M. M., Carroll, S. L., Chui, H. C., Clark, D. G., Corneveaux, J., Cribbs, D. H., Crocco, E. A., DeCarli, C., DeKosky, S. T., Dick, M., Dickson, D. W., Duara, R., Faber, K. M., Fallon, K. B., Farlow, M. R., Ferris, S., Frosch, M. P., Galasko, D. R., Ganguli, M., Gearing, M., Geschwind, D. H., Ghetti, B., Gilbert, J. R., Glass, J. D., Growdon, J. H., Hamilton, R. L., Harrell, L. E., Head, E., Honig, L. S., Hulette, C. M., Hyman, B. T., Jicha, G. A., Jin, L. - W., Karydas, A., Kaye, J. A., Kim, R., Koo, E. H., Kowall, N. W., Kramer, J. H., LaFerla, F. M., Lah, J. J., Leverenz, J. B., Levey, A. I., Li, G., Lieberman, A. P., Lin, C. - F., Lopez, O. L., Lyketsos, C. G., Mack, W. J., Martiniuk, F., Mash, D. C., Masliah, E., McCormick, W. C., McCurry, S. M., McDavid, A. N., McKee, A. C., Mesulam, M., Miller, B. L., Miller, C. A., Miller, J. W., Murrell, J. R., Olichney, J. M., Pankratz, V. S., Parisi, J. E., Paulson, H. L., Peskind, E., Petersen, R. C., Pierce, A., Poon, W. W., Potter, H., Quinn, J. F., Raj, A., Raskind, M., Reisberg, B., Ringman, J. M., Roberson, E. D., Rosen, H. J., Rosenberg, R. N., Sano, M., Schneider, L. S., Seeley, W. W., Smith, A. G., Sonnen, J. A., Spina, S., Stern, R. A., Tanzi, R. E., Thornton-Wells, T. A., Trojanowski, J. Q., Troncoso, J. C., Valladares, O., Van Deerlin, V. M., Van Eldik, L. J., Vardarajan, B. N., Vinters, H. V., Vonsattel, J. Paul, Weintraub, S., Welsh-Bohmer, K. A., Williamson, J., Wishnek, S., Woltjer, R. L., Wright, C. B., Younkin, S. G., Yu, C. - E., and Yu, L., “Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.”, JAMA Neurol, vol. 71, no. 11, pp. 1394-404, 2014.

M. Thambisetty, An, Y., and Tanaka, T., “Alzheimer's disease risk genes and the age-at-onset phenotype.”, Neurobiol Aging, vol. 34, no. 11, pp. 2696.e1-5, 2013.

J. M. van der Walt, Dementieva, Y. A., Martin, E. R., Scott, W. K., Nicodemus, K. K., Kroner, C. C., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Small, G. W., Schmechel, D. E., P Doraiswamy, M., Gilbert, J. R., Haines, J. L., Vance, J. M., and Pericak-Vance, M. A., “Analysis of European mitochondrial haplogroups with Alzheimer disease risk.”, Neurosci Lett, vol. 365, no. 1, pp. 28-32, 2004.

W. A. Kukull, Schellenberg, G. D., Bowen, J. D., McCormick, W. C., Yu, C. E., Teri, L., Thompson, J. D., O'Meara, E. S., and Larson, E. B., “Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.”, J Clin Epidemiol, vol. 49, no. 10, pp. 1143-8, 1996.

W. A. Kukull, Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., and Larson, E. B., “Dementia and Alzheimer disease incidence: a prospective cohort study.”, Arch Neurol, vol. 59, no. 11, pp. 1737-46, 2002.

Y. Li, Chen, J. A., Sears, R. L., Gao, F., Klein, E. D., Karydas, A., Geschwind, M. D., Rosen, H. J., Boxer, A. L., Guo, W., Pellegrini, M., Horvath, S., Miller, B. L., Geschwind, D. H., and Coppola, G., “An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy.”, PLoS Genet, vol. 10, no. 3, p. e1004211, 2014.

P. L. De Jager, Shulman, J. M., Chibnik, L. B., Keenan, B. T., Raj, T., Wilson, R. S., Yu, L., Leurgans, S. E., Tran, D., Aubin, C., Anderson, C. D., Biffi, A., Corneveaux, J. J., Huentelman, M. J., Rosand, J., Daly, M. J., Myers, A. J., Reiman, E. M., Bennett, D. A., and Evans, D. A., “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.

S. Mukherjee, Walter, S., Kauwe, J. S. K., Saykin, A. J., Bennett, D. A., Larson, E. B., Crane, P. K., and M Glymour, M., “Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.”, Alzheimers Dement, vol. 11, no. 12, pp. 1439-1451, 2015.

C. Cruchaga, Kauwe, J. S. K., Harari, O., Jin, S. Chih, Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., Bertelsen, S., Bailey, M., McKean, D., Shulman, J. M., De Jager, P. L., Chibnik, L., Bennett, D. A., Arnold, S. E., Harold, D., Sims, R., Gerrish, A., Williams, J., Van Deerlin, V. M., Lee, V. M. - Y., Shaw, L. M., Trojanowski, J. Q., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Schellenberg, G. D., Peskind, E. R., Galasko, D., Fagan, A. M., Holtzman, D. M., Morris, J. C., and Goate, A. M., “GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.”, Neuron, vol. 78, no. 2, pp. 256-68, 2013.

E. M. Reiman, Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., Craig, D. W., Coon, K. D., Liang, W. S., Herbert, R. L. H., Beach, T., Rohrer, K. C., Zhao, A. S., Leung, D., Bryden, L., Marlowe, L., Kaleem, M., Mastroeni, D., Grover, A., Heward, C. B., Ravid, R., Rogers, J., Hutton, M. L., Melquist, S., Petersen, R. C., Alexander, G. E., Caselli, R. J., Kukull, W., Papassotiropoulos, A., and Stephan, D. A., “GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.”, Neuron, vol. 54, no. 5, pp. 713-20, 2007.

Y. Deming, Li, Z., Kapoor, M., Harari, O., Del-Aguila, J. L., Black, K., Carrell, D., Cai, Y., Fernández, M. Victoria, Budde, J., Ma, S., Saef, B., Howells, B., Huang, K. - L., Bertelsen, S., Fagan, A. M., Holtzman, D. M., Morris, J. C., Kim, S., Saykin, A. J., De Jager, P. L., Albert, M., Moghekar, A., O'Brien, R., Riemenschneider, M., Petersen, R. C., Blennow, K., Zetterberg, H., Minthon, L., Van Deerlin, V. M., Lee, V. Man- Yee, Shaw, L. M., Trojanowski, J. Q., Schellenberg, G., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Peskind, E. R., Li, G., Di Narzo, A. F., Kauwe, J. S. K., Goate, A. M., and Cruchaga, C., “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.

K. K. Nicodemus, Stenger, J. E., Schmechel, D. E., Welsh-Bohmer, K. A., Saunders, A. M., Roses, A. D., Gilbert, J. R., Vance, J. M., Haines, J. L., Pericak-Vance, M. A., and Martin, E. R., “Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.”, Neurogenetics, vol. 5, no. 4, pp. 201-8, 2004.

S. Smemo, Nowotny, P., Hinrichs, A. L., Kauwe, J. S. K., Cherny, S., Erickson, K., Myers, A. J., Kaleem, M., Marlowe, L., Gibson, A. M., Hollingworth, P., O'Donovan, M. C., Morris, C. M., Holmans, P., Lovestone, S., Morris, J. C., Thal, L., Li, Y., Grupe, A., Hardy, J., Owen, M. J., Williams, J., and Goate, A., “Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.”, Ann Neurol, vol. 59, no. 1, pp. 21-6, 2006.

C. Reitz, Tosto, G., Vardarajan, B., Rogaeva, E., Ghani, M., Rogers, R. S., Conrad, C., Haines, J. L., Pericak-Vance, M. A., Fallin, M. D., Foroud, T., Farrer, L. A., Schellenberg, G. D., George-Hyslop, P. S., and Mayeux, R., “Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).”, Transl Psychiatry, vol. 3, p. e256, 2013.

Risk Assessment

Y. - J. Li, Scott, W. K., Zhang, L., Lin, P. - I., Oliveira, S. A., Skelly, T., Doraiswamy, M. P., Welsh-Bohmer, K. A., Martin, E. R., Haines, J. L., Pericak-Vance, M. A., and Vance, J. M., “Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases.”, Neurobiol Aging, vol. 27, no. 8, pp. 1087-93, 2006.

Risk

R. C. Green, L Cupples, A., Go, R., Benke, K. S., Edeki, T., Griffith, P. A., Williams, M., Hipps, Y., Graff-Radford, N., Bachman, D., and Farrer, L. A., “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.

J. A. Chen, Wang, Q., Davis-Turak, J., Li, Y., Karydas, A. M., Hsu, S. C., Sears, R. L., Chatzopoulou, D., Huang, A. Y., Wojta, K. J., Klein, E., Lee, J., Beekly, D. L., Boxer, A., Faber, K. M., Haase, C. M., Miller, J., Poon, W. W., Rosen, A., Rosen, H., Sapozhnikova, A., Shapira, J., Varpetian, A., Foroud, T. M., Levenson, R. W., Levey, A. I., Kukull, W. A., Mendez, M. F., Ringman, J., Chui, H., Cotman, C., DeCarli, C., Miller, B. L., Geschwind, D. H., and Coppola, G., “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.

E. S. O'Meara, Kukull, W. A., Sheppard, L., Bowen, J. D., McCormick, W. C., Teri, L., Pfanschmidt, M., Thompson, J. D., Schellenberg, G. D., and Larson, E. B., “Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.”, Am J Epidemiol, vol. 146, no. 5, pp. 373-84, 1997.

G. W. Beecham, Martin, E. R., Li, Y. - J., Slifer, M. A., Gilbert, J. R., Haines, J. L., and Pericak-Vance, M. A., “Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease.”, Am J Hum Genet, vol. 84, no. 1, pp. 35-43, 2009.